BSE filing, NSE: LAXMIDENTL. Summary written from the filing by ALFA Finder's alert engine.
Laxmi Dental Ltd: key numbers
- Share price
- ₹181.51
- Market cap
- ₹998.8 Cr
- Revenue (annual)
- ₹277.9 Cr
- Net profit (annual)
- ₹28.98 Cr
- P/E (TTM)
- 32.3×Sector 53.7×
- Promoter holding
- 41.75%-0.05% QoQ
- FII holding
- 6.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Laxmi Dental Ltd
All →Laxmi Dental Investor Presentation: Key Takeaways
Q2FY27 revenue ₹79.5 Cr (+10% YoY), a record quarter. EBITDA margin 19.2%, PAT ₹10.0 Cr (+17.6%). H1FY27 revenue ₹154.2 Cr (+11.9%).
Laxmi Dental Q2 FY27 Results: Net Profit ₹10 Cr, Up 17.6% YoY
Laxmi Dental Ltd reported revenue from operations of ₹79.5 Cr (+10.0% YoY) and net profit of ₹10 Cr (+17.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹10 Cr · +17.6% YoY
Laxmi Dental Board Meeting Date
Laxmi Dental scheduled a board meeting for November 3, 2026, to consider unaudited Q1 FY27 financial results. No financial figures are disclosed in this prior intimation.
Laxmi Dental Merger & Restructuring
Laxmi Dental Limited announced the incorporation of Leelaben Foundation, a Section 8 company, in which the company is a member, as previously approved by its board.
Laxmi Dental Business Update
Laxmi Dental's subsidiary received a tariff refund of ₹5.92 Crore from U.S. Customs following a regulatory change regarding excess tariffs collected.
- Value
- ₹5.92 Cr
- From
- U.S. Customs and Border Protection (CBP)
Laxmi Dental Legal & Regulatory
Laxmi Dental Limited's subsidiary, Laxmi Dental Lab USA, INC, received a tariff refund of approximately INR 5.92 Crore from U.S. Customs and Border Protection.
- Value
- ₹5.92 Cr
Other results update announcements
All →Multi Commodity Exchange of India Results Update
MCX reported H1FY27 consolidated revenue of ₹1,502 crore, up 100.8% YoY, and PAT of ₹868 crore. Q2FY27 PAT rose 130.8% YoY to ₹455 crore.
Shanti Gold International Results Update
Shanti Gold reported H1 FY27 revenue of Rs. 1,462.3 crore and PAT of Rs. 80.0 crore. Revenue doubled, but Q2 EBITDA margin compressed to 5.7%.
Aarti Drugs Results Update
Aarti Drugs reports Q2 FY27 revenue of ₹828.8 Crore and PAT of ₹82.8 Crore, up 83% YoY. Results reflect record quarterly EBITDA and margin expansion.
Fine Organic Industries Results Update
Fine Organic reports Q2 FY27 revenue of ₹729.4 Crore and PAT of ₹152.1 Crore, up 40.1%. Results show strong year-on-year growth across revenue, EBITDA and profit.
Jyoti Structures Results Update
Jyoti Structures reported standalone Q2 FY27 total income up 60.2% to Rs 248.57 crore and PAT of Rs 15.37 crore. The order book stood at Rs 4,219 crore as of September 30, 2026.
Samhi Hotels Results Update
SAMHI Hotels reported unaudited Q2 and H1 FY27 results, with Q2 total income up 15.6% to Rs 3,427 Mn and PAT of Rs 411 Mn. Management highlighted same-store growth and a pipeline of about 1,700 new rooms through FY2031.